2023 - Research.com Neuroscience in Austria Leader Award
2020 - Member of Academia Europaea
Member of the European Academy of Sciences and Arts
Siegfried Kasper focuses on Internal medicine, Psychiatry, Endocrinology, Antidepressant and Depression. His Internal medicine research includes themes of Placebo, Light therapy, Agomelatine and Atypical antipsychotic. His Psychiatry study combines topics in areas such as Evidence-based medicine and MEDLINE.
His studies deal with areas such as Genotype and Serotonin as well as Endocrinology. His research in Antidepressant focuses on subjects like Pharmacology, which are connected to Clozapine. His Depression research includes elements of Morning and Hypericum perforatum.
Siegfried Kasper mostly deals with Psychiatry, Internal medicine, Depression, Endocrinology and Antidepressant. His Psychiatry study frequently links to adjacent areas such as Clinical psychology. Siegfried Kasper has included themes like Placebo and Treatment-resistant depression in his Internal medicine study.
His research on Placebo frequently links to adjacent areas such as Randomized controlled trial. He is interested in Light therapy, which is a branch of Depression. He has researched Antidepressant in several fields, including Anesthesia and Pharmacology.
Siegfried Kasper mainly investigates Psychiatry, Internal medicine, Major depressive disorder, Depression and Neuroscience. His Psychiatry study incorporates themes from Clinical trial, Randomized controlled trial and MEDLINE. His study in Internal medicine is interdisciplinary in nature, drawing from both Placebo, Endocrinology and Oncology.
Siegfried Kasper focuses mostly in the field of Major depressive disorder, narrowing it down to matters related to Clinical psychology and, in some cases, Anxiety. Siegfried Kasper regularly links together related areas like Rating scale in his Depression studies. Siegfried Kasper works mostly in the field of Neuroscience, limiting it down to topics relating to Serotonergic and, in certain cases, Serotonin transporter, as a part of the same area of interest.
His scientific interests lie mostly in Psychiatry, Internal medicine, Major depressive disorder, Depression and Treatment-resistant depression. His Psychiatry research integrates issues from Clinical trial and Intensive care medicine. His work deals with themes such as Endocrinology and Drug, which intersect with Internal medicine.
His study looks at the intersection of Endocrinology and topics like Serotonin transporter with Binding potential. His Major depressive disorder research is multidisciplinary, incorporating perspectives in Antidepressant, Escitalopram, Oncology and Clinical psychology. His Depression study combines topics in areas such as Prevalence, Comorbidity, Antipsychotic and Rating scale.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Epidemiological findings of seasonal changes in mood and behavior. A telephone survey of Montgomery County, Maryland.
Siegfried Kasper;Thomas A. Wehr;John J. Bartko;Paul A. Gaist.
Archives of General Psychiatry (1989)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision
Borwin Bandelow;Josef Zohar;Eric Hollander;Siegfried Kasper.
World Journal of Biological Psychiatry (2002)
Prevalence of seasonal affective disorder at four latitudes.
Leora N. Rosen;Steven D. Targum;Michael Terman;Michael J. Bryant.
Psychiatry Research-neuroimaging (1990)
The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders
Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen.
American Journal of Psychiatry (2013)
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the Acute and Continuation Treatment of Unipolar Depressive Disorders
Michael Bauer;Andrea Pfennig;Emanuel Severus;Peter C. Whybrow.
World Journal of Biological Psychiatry (2013)
Social functioning in depression: a review
Robert M.A. Hirschfeld;Stuart A. Montgomery;Martin B. Keller;Siegfried Kasper.
The Journal of Clinical Psychiatry (2000)
CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.
J Kirchheiner;K Brosen;Marja-Liisa Dahl;LF Gram.
Acta Psychiatrica Scandinavica (2001)
Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.
Daniel Souery;Pierre Oswald;Isabelle Massat;Ursula Bailer.
The Journal of Clinical Psychiatry (2007)
A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder.
Guy M. Goodwin;Charles L. Bowden;Joseph R. Calabrese;Heinz Grunze.
The Journal of Clinical Psychiatry (2004)
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression.
Heinz Grunze;Eduard Vieta;Guy M. Goodwin;Charles Bowden.
World Journal of Biological Psychiatry (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: